Industrias Quimicas Falcon de Mexico, SA de CV (Dr. Reddy's Mexico) – FDA EIR, Jul 20, 2017

An FDA inspection of Industrias Quimicas Falcon de Mexico SA de CV (Dr. Reddys), a manufacturer of human and animal Active Pharmaceutical Ingredients (APIs), was conducted from July 17 to July 20, 2017. The inspection was performed under the FY 17 workplan, specifically following Compliance Program 7356.002F for API process inspections and 7371.001 for animal drug manufacturing. The company manufactures chemically synthesized APIs.

Significantly, the inspection concluded with a "No Action Indicated (NAI)" classification, indicating that no significant regulatory violations were identified. The FDA did not issue any Form 483 observations, which are typically used to document objectionable conditions or practices. This outcome reflects that the company was found to be operating in compliance with current Good Manufacturing Practices (cGMP) for API manufacturing.

While no violations were cited, the report noted two discussion items, though specifics were not detailed. No samples were collected, and there were no inspection refusals or recalls reported since the previous inspection in 2015. Consequently, no specific regulatory actions were required from the firm following this inspection, reinforcing its compliant status.